Dear Stakeholders,
We are pleased to announce that the final version of the ICH E6(R3) Good Clinical Practice (GCP) guideline has been published. Singapore will implement the Principles and Annex 1 document of this revised guideline on 1 January 2026, with a one-year transition period for stakeholders to adapt their Quality Management Systems.
To support this transition, the Singapore Clinical Research Institute (SCRI) and the Health Sciences Authority (HSA) will be hosting a public webinar to provide an overview of the major changes in ICH E6(R3) GCP. Both SCRI and Universiti Malaya Medical Centre (UMMC) are members of the International Clinical Trial Centre Network (ICN), reinforcing our commitment to global clinical research standards.
📅 Date: 28 February 2025 (Friday)
⏰ Time: 1:00 PM – 5:00 PM (SGT)
📍 Mode: Webinar
🎤 Speaker: Sumitra Sachidanandan, Regulatory Consultant, HSA
💡 Key Topics:
✅ Overview of major changes to ICH E6(R3) GCP Principles & Annex 1
✅ Proportionate training recommendations for implementation
✅ Q&A session with regulatory experts
🔗 Register now: Click here
⏳ Registration Deadline: 21 February 2025
Don’t miss this opportunity to stay updated on the latest GCP revisions!
